๐๐๐ฏ๐๐ง ๐๐ก๐ข๐ง๐ ๐ฌ ๐ ๐๐ ๐๐ง๐ฏ๐๐ฌ๐ญ๐ข๐ ๐๐ญ๐จ๐ซ๐ฌ ๐๐จ๐ญ๐ข๐๐ ๐๐๐๐จ๐ซ๐ ๐๐ก๐๐ฒ ๐๐ฌ๐ค ๐๐จ๐ซ ๐ ๐๐ข๐ง๐ ๐ฅ๐ ๐๐จ๐๐ฎ๐ฆ๐๐ง๐ญ
Most companies spend months preparing their documents for an FDA inspection. The Investigator has already formed an opinion about your facility before your document coordinator brings out the first record.
I spent 14 years as an FDA Investigator and issued more Form 483s than I care to count. For the 13 years afterwards, I was directly responsible for FDA 483s received at multiple companies. Here is something the industry does not talk about enough. The inspection does not start when the Investigator sits down and asks for your batch records. It starts the moment we pull into your parking lot. Sometimes earlier - the night before, when we are reviewing your establishment inspection history, your prior 483 observations, and every Warning Letter your site or your parent company has ever received.
By the time you hand us a document, we already have a working theory about your facility. What we are doing for the rest of the inspection, in many respects, is testing that theory.
What follows are seven things I noticed - and that every Investigator I know notices - before a single document changes hands. Some of them will surprise you. All of them are controllable. And all of them are shaping the Investigatorโs mindset before your quality director says good morning.
The seven observations cover what Investigators watch for during the facility walkthrough - before your documentation team is involved at all. These are the moments that set the tone for everything that follows. Paid subscribers get the complete list, the insider context behind each one, and the specific corrective actions that change what an Investigator concludes before the formal inspection even begins.
PAID SECTION - The Investigatorโs Lens

